$GNLX
Genelux Corporation Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is GNLX down today? It is at $2.72 (-0.73%), and our scanner flagged it 6 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment GNLX spikes, and full due diligence on GNLX — key stats, earnings, dilution and insider activity. Free.
Get free $GNLX alerts the moment volume spikes
Our scanner flagged $GNLX 6 times in the last 30 days. Create a free account to track $GNLX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $2.72
- Change today
- -0.73%
- Previous close
- $2.74
- 52-week range
- $2.29 – $8.54
- Market cap
- $123M
- Institutional own.
- 25.11%
- Total held
- 33.0%
- Tradeable float
- 30.3M 67% of shares · after 8% insiders + 25% institutions
- Short interest
- 3.1M ▼ -1% vs prior · as of 2026-07-31
- Short % of float
- 10.2%
- Days to cover
- 20.1d
- Avg daily volume
- 218K
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Exchange
- XNAS
- 5m
- 1.1x
- 15m
- 1.1x
- 1h
- 1.0x
- 1D
- --
Get free GNLX + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $GNLX down today?
Here is the latest on GNLX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for GNLX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystGENELUX Corp: Q2 FY2026 results, three months to Jun 30, 2026, from the latest SEC filing. Read it →Analyst data via Nasdaq. Not investment advice.
Insiders
Insiders buying9 buys, 6 sells last 3 months (18/23 over 12 months)Show 12 recent transactionsMinimize 12 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Yu Yong Officer | Sold (automatic/other) | -653 | sold 0.2% | 268K | $2K at $2.94 | Aug 4, 26 |
Zindrick Thomas Officer | Sold (automatic/other) | -3K | sold 0.2% | 1.26M | $9K at $2.95 | Aug 4, 26 |
Cappello Joseph Officer | Sold (automatic/other) | -653 | sold 0.2% | 329K | $2K at $2.95 | Aug 4, 26 |
Smither John W Director | Sold (automatic/other) | -12K 0.03% of company | sold 12% | 91K | $35K at $2.91 | Jul 1, 26 |
Yu Yong Officer | Acquired (grant/award) | +119K 0.3% of company | added 80% | 269K | n/a | Jun 16, 26 |
Smither John W Director | Acquired (grant/award) | +28K 0.06% of company | added 38% | 103K | n/a | Jun 16, 26 |
Cappello Joseph Officer | Acquired (grant/award) | +175K 0.4% of company | added 100% | 329K | n/a | Jun 16, 26 |
Mirabelli Mary Director | Acquired (grant/award) | +28K 0.06% of company | added 38% | 103K | n/a | Jun 16, 26 |
Pulisic Matthew Officer | Acquired (grant/award) | +279K 0.6% of company | n/a | 279K | n/a | Jun 16, 26 |
Tyree James L Director | Acquired (grant/award) | +28K 0.06% of company | added 42% | 96K | n/a | Jun 16, 26 |
Zindrick Thomas Officer | Acquired (grant/award) | +731K 1.6% of company | added 100% | 1.26M | n/a | Jun 16, 26 |
Thomas John Director | Acquired (grant/award) | +28K 0.06% of company | added 6.0% | 501K | n/a | Jun 16, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Dilution watch
Recent offeringAt-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing). If $GNLX runs, these filings show who may be positioned to sell new or newly-registered shares into the move.
- 38,610,039 new shares · At-the-market (ATM) program — sells new shares into the market gradually over time · About $100.0M in size · Priced at $2.59/share
Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.
$GNLX Sentiment
BullishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$GNLX Activity
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Stocks similar to GNLX
Comparable names in pharmaceutical preparations, closest in size first.
GNLX stock FAQ
Why is $GNLX down today?
Here is the latest on GNLX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for GNLX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
What is the GNLX stock price today?
GNLX last traded at $2.72, down 0.73% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Where can I see live GNLX alerts?
The GNLX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged GNLX 6 times in the last 30 days.
What exchange is GNLX on?
GNLX (Genelux Corporation Common Stock) trades on XNAS, with a market cap of about $123M in the PHARMACEUTICAL PREPARATIONS sector.
Is GNLX good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge GNLX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.